# Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea

> **NCT01374490** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 250 (actual)

## Conditions studied

- HIV Enteropathy
- Diarrhea With HIV

## Interventions

- **DRUG:** Crofelemer

## Key facts

- **NCT ID:** NCT01374490
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-07
- **Primary completion:** 2012-10-31
- **Final completion:** 2012-10-31
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2020-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01374490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01374490, "Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01374490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*